X

Vous n'êtes pas connecté

  - DRUGS.COM - Clinical Trials News - 12/07/2024 03:07

Niclosamide-based Metabolic Anticancer Drug's First Clinical Trial Target are Prostate Cancer Patients Resistant to Hormone Therapy

SEOUL, South Korea, July 11, 2024. ADM Korea, a subsidiary of Hyundai Bioscience, announced on the 8th that the first clinical trial target population for its niclosamide-based oral metabolic anticancer drug will be 'prostate cancer patients...

Articles similaires

Sorry! Image not available at this time

Servier India introduces 'Ivosidenib' in India, first─in─class targeted therapy in oncology for rare IDH1─mutated AML & CCA

pharmabiz.com - 21/Jun 21:02

Servier India, a subsidiary of the leading French pharmaceutical Servier Group, recently announced the launch of Ivosidenib (Tibsovo), an oral...

Sorry! Image not available at this time

Servier India introduces 'Ivosidenib' in India, first─in─class targeted therapy in oncology for rare IDH1─mutated AML & CCA

pharmabiz.com - 21/Jun 21:02

Servier India, a subsidiary of the leading French pharmaceutical Servier Group, recently announced the launch of Ivosidenib (Tibsovo), an oral...

Aromatic benzaldehyde inhibits growth of therapy-resistant pancreatic cancer

news.medical.net - 02/Jul 16:25

During therapy, some cancer cells evolve to escape elimination. Newer anticancer drugs that can overcome this resistance are necessary.

Biomarkers Pave Way for Targeted Prostate Cancer Therapy

medindia.net - 21/Jun 20:54

Many men with aggressive medlinkprostate cancer/medlink often face a high risk of the disease returning even after treatment. A recent Phase 2...

Biomarkers Pave Way for Targeted Prostate Cancer Therapy

medindia.net - 21/Jun 20:54

Many men with aggressive medlinkprostate cancer/medlink often face a high risk of the disease returning even after treatment. A recent Phase 2...

Sorry! Image not available at this time

Lilly’s experimental obesity pill holds up to scrutiny in trial

wn.com - 21/Jun 23:04

Eli Lilly & Co.’s experimental weight loss pill helped patients shed pounds without serious side effects in a clinical trial, burnishing the...

Sorry! Image not available at this time

Lilly’s experimental obesity pill holds up to scrutiny in trial

wn.com - 21/Jun 23:04

Eli Lilly & Co.’s experimental weight loss pill helped patients shed pounds without serious side effects in a clinical trial, burnishing the...

Botox mitigates debilitating dry mouth in prostate cancer patients receiving radiopharmaceutical therapy

oncologynews.com.au - 30/Jun 12:15

A dual-protective approach using botulinum toxin (Botox) alongside an anti-nausea patch significantly reduces salivary gland toxicity in patients with...